Page last updated: 2024-11-04

semustine and Leukemia L 1210

semustine has been researched along with Leukemia L 1210 in 18 studies

Semustine: 4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
semustine : An organochlorine compound that is urea in which the two hydrogens on one of the amino groups are replaced by nitroso and 2-chloroethyl groups and one hydrogen from the other amino group is replaced by a 4-methylcyclohexyl group.

Research Excerpts

ExcerptRelevanceReference
"The therapeutic usefulness of chlorpromazine (CPZ) and caffeine (CAF) in combination with selected nitrosoureas was investigated in mice bearing L1210 leukemia, Lewis lung carcinoma, and B16 melanoma."3.66Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors. ( Dykes, DJ; Laster, WR; Rose, WC; Schabel, FM; Trader, MW, 1978)
" Immunotherapy with VCN-treated membranes was effective only when combined with 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (MeCCNU)."1.26Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy. ( Brandt, AE; Jameson, AK; Pincus, JH, 1981)
"Studies have been conducted on liver microsomal enzymes of B6D2F(1) mice bearing a Day 4 L1210 ascites tumor after treatment with a single intraperitoneal injection of 5-fluorouracil (FUra) alone, and in combination with either cyclophosphamide (CP), methotrexate (MTX), or methyl-CCNU (MeCCNU)."1.26Studies of the effects of treatment with 5-flourouracil alone and in combination with either cyclophosphamide, methotrexate, or methyl-CCNU on hepatic drug-metabolizing enzymes in murine L1210 leukemia. ( Klubes, P; Miller, HG; Trevithick, J, 1980)

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-199018 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crider, AM1
Lu, CK1
Floss, HG1
Cassady, JM1
Clemens, JA1
Johnston, TP2
McCaleb, GS2
Clayton, SD1
Frye, JL1
Krauth, CA1
Montgomery, JA3
Mayo, JG1
Laster, WR2
Hansch, C1
Leo, A1
Schmidt, C1
Jow, PY1
Oguro, M1
Yanagawa, T1
Takenaga, K1
Brandt, AE2
Pincus, JH1
Jameson, AK1
Griswold, DP1
Corbett, TH1
Schabel, FM3
Klubes, P1
Trevithick, J1
Miller, HG1
Papermaster, BW1
Kaltenbach, ML1
Rose, WC1
Trader, MW1
Dykes, DJ1
Bekesi, JG1
Roboz, JP1
Zimmerman, E1
Holland, JF1
Carchman, RA1
Harris, LS1
Munson, AE1
Young, RC1
Goldberg, D1
Grotzinger, KR1
Schmid, FA2
Otter, GM2
Hirano, I1
Chen, CF1
Spreafico, F1
Garattini, S1

Reviews

2 reviews available for semustine and Leukemia L 1210

ArticleYear
Nitrosoureas: a review of experimental antitumor activity.
    Cancer treatment reports, 1976, Volume: 60, Issue:6

    Topics: Animals; Carmustine; Colonic Neoplasms; Drug Evaluation, Preclinical; Drug Resistance; Drug Therapy,

1976
Selective antimetastatic treatment--current status and future prospects.
    Cancer treatment reviews, 1974, Volume: 1, Issue:4

    Topics: Animals; Carcinoma, Ehrlich Tumor; Cyclophosphamide; Drug Evaluation, Preclinical; Humans; Immunothe

1974

Other Studies

16 other studies available for semustine and Leukemia L 1210

ArticleYear
Ergot alkaloids. Synthesis of nitrosourea derivatives of ergolines as potential anticancer agents.
    Journal of medicinal chemistry, 1979, Volume: 22, Issue:1

    Topics: Animals; Antineoplastic Agents; Ergolines; Leukemia L1210; Mice; Nitrosourea Compounds; Prolactin; R

1979
Synthesis of analogues of N-(2-chloroethyl)-N'-(trans-4-methylcyclohexyl)-N-nitrosourea for evaluation as anticancer agents.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:2

    Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Isomerism; Leukemia L1210; Mice; Mice

1977
Inhibition of solid tumors by nitrosoureas. 1. Lewis lung carcinoma.
    Journal of medicinal chemistry, 1977, Volume: 20, Issue:2

    Topics: Animals; Carcinoma; Leukemia L1210; Lung Neoplasms; Mice; Mice, Inbred Strains; Neoplasms, Experimen

1977
Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Journal of medicinal chemistry, 1980, Volume: 23, Issue:10

    Topics: Animals; Antineoplastic Agents; Leukemia L1210; Mice; Models, Theoretical; Nitrosourea Compounds; So

1980
[Antitumor activity of a new nitrosourea, MCNU, on a cellular morphological basis evaluated by a new in vitro antitumor sensitivity assay].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1984, Volume: 11, Issue:12 Pt 1

    Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Drug Re

1984
Correspondence re: J. H. Pincus, A. K. Jameson, and A. E. Brandt. Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy. Cancer Res., 41: 3082-3086, 1981.
    Cancer research, 1982, Volume: 42, Issue:10

    Topics: Animals; Carmustine; Cell Membrane; Immunotherapy; Leukemia L1210; Mice; Neuraminidase; Semustine

1982
Immunotherapy of L1210 leukemia using neuraminidase-modified plasma membranes combined with chemotherapy.
    Cancer research, 1981, Volume: 41, Issue:8

    Topics: Animals; Antineoplastic Agents; Cell Membrane; Female; Immunotherapy; Leukemia L1210; Mice; Neuramin

1981
Clonogenicity and growth of experimental tumors in relation to developing resistance and therapeutic failure.
    Cancer treatment reports, 1981, Volume: 65 Suppl 2

    Topics: Animals; Clone Cells; Cyclophosphamide; Drug Resistance; Humans; Leukemia L1210; Melanoma; Mice; Neo

1981
Studies of the effects of treatment with 5-flourouracil alone and in combination with either cyclophosphamide, methotrexate, or methyl-CCNU on hepatic drug-metabolizing enzymes in murine L1210 leukemia.
    Archives internationales de pharmacodynamie et de therapie, 1980, Volume: 246, Issue:1

    Topics: Animals; Cyclophosphamide; Drug Interactions; Fluorouracil; Leukemia L1210; Liver; Male; Methotrexat

1980
Lymphokine preparations: a new approach to cancer immunotherapy.
    Missouri medicine, 1978, Volume: 75, Issue:12

    Topics: Animals; Guinea Pigs; Humans; Immunity, Cellular; Immunotherapy; Leukemia L1210; Lymphokines; Lympho

1978
Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
    Cancer treatment reports, 1978, Volume: 62, Issue:12

    Topics: Animals; Caffeine; Carmustine; Chlorpromazine; Drug Synergism; Drug Therapy, Combination; Female; Le

1978
Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
    Cancer research, 1976, Volume: 36, Issue:2 pt 2

    Topics: AKR murine leukemia virus; Animals; Antibodies, Viral; Antigens, Neoplasm; Antineoplastic Agents; Dr

1976
The inhibition of DNA synthesis by cannabinoids.
    Cancer research, 1976, Volume: 36, Issue:1

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Cannabidiol; Cannabis; Cyclophosphamide; Cytarabine; DNA; D

1976
Alterations in 3H-thymidine incorporation into DNA induced by methyl CCNU (1-(2-chloroethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea) in normal and tumorous tissues in vivo.
    Cell and tissue kinetics, 1976, Volume: 9, Issue:4

    Topics: Animals; Bone Marrow; DNA; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Intesti

1976
L1210 leukemia hybrids isolated after fusion of alkylating agent-resistant sublines.
    Leukemia research, 1988, Volume: 12, Issue:1

    Topics: Alkylating Agents; Animals; Cell Fusion; Cell Line; Cell Separation; Chromosomes; Cyclophosphamide;

1988
Drug sensitivity of methylnitrosourea- and 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea-resistant L1210 lines.
    Cancer research, 1986, Volume: 46, Issue:9

    Topics: Alkylating Agents; Animals; Antimetabolites, Antineoplastic; Cell Line; Cell Survival; Drug Administ

1986